Axogen (AXGN) Capital Expenditures (QoQ) (2012 - 2026)
Axogen (AXGN) Capital Expenditures (QoQ) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Axogen | 2.05 Bn | 1.95 Bn | 46.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.52% |
| Dec 31, 2025 | 3,274.04% |
| Sep 30, 2025 | 183.87% |
| Jun 30, 2025 | -148.44% |
| Mar 31, 2025 | -91.43% |
| Dec 31, 2024 | 4,767.19% |
| Sep 30, 2024 | 91.42% |
| Jun 30, 2024 | -180.74% |
| Mar 31, 2024 | -36.84% |
| Dec 31, 2023 | -86.19% |
| Sep 30, 2023 | 1,237.25% |
| Jun 30, 2023 | -22.81% |
| Mar 31, 2023 | -84.51% |
| Dec 31, 2022 | -43.11% |
| Sep 30, 2022 | 1,567.48% |
| Jun 30, 2022 | -37.62% |
| Mar 31, 2022 | -84.39% |
| Dec 31, 2021 | -59.28% |
| Sep 30, 2021 | 1,077.57% |
| Jun 30, 2021 | -137.24% |